We are live on
!
Find out more
CTIC
CTI BioPharma Corp. (DE) Common Stock
CTIC
CTIC
Delisted
CTIC was delisted on the 23rd of June, 2023.
79 hedge funds and large institutions have $76.7M invested in CTI BioPharma Corp. (DE) Common Stock in 2018 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 22 increasing their positions, 21 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
467% more call options, than puts
Call options by funds: $119K | Put options by funds: $21K
5% more repeat investments, than reductions
Existing positions increased: 22 | Existing positions reduced: 21
5% less funds holding
Funds holding: 83 → 79 (-4)
27% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 15
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
62% less capital invested
Capital invested by funds: $200M → $76.7M (-$124M)
Holders
79
Holders Change
-4
Holders Change %
-4.82%
% of All Funds
1.81%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
11
Increased
22
Reduced
21
Closed
15
Calls
$119K
Puts
$21K
Net Calls
+$98K
Net Calls Change
-$197K
Top Buyers
Top Sellers
| 1 |
Franklin Resources
San Mateo,
California
|
-$17.3M |
| 2 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$4.36M |
| 3 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$3.75M |
| 4 |
Millennium Management
New York
|
-$3.37M |
| 5 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$3.01M |
